Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
21.14
+0.10 (0.48%)
Nov 13, 2026, 4:00 PM EST - Market closed
Tectonic Therapeutic Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
60
Market Cap
413.27M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Puma Biotechnology | 231.83M |
| ARS Pharmaceuticals | 122.14M |
| Assembly Biosciences | 67.01M |
| Prothena Corporation | 52.74M |
| Opus Genetics | 7.91M |
| SL Science Holding | 3.27M |
| Lyell Immunopharma | 15.00K |
TECX News
- 3 days ago - Tectonic Therapeutic Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 6 days ago - Tectonic Therapeutic to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 9 days ago - Tectonic Therapeutic reports Q3 EPS ($1.08) vs. ($1.02) last year - TheFly
- 9 days ago - Tectonic Therapeutic Announces Third Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 10 days ago - Tectonic Therapeutic Quarterly report: Q3 2026 - Filings
- 10 days ago - Tectonic Therapeutic Earnings release: Q3 2026 - Filings
- 25 days ago - Tectonic Therapeutic management to meet with Piper Sandler - TheFly
- 4 weeks ago - Tectonic Therapeutic Slides: Conference presentation - Filings